The Next Short Squeeze Target - OTRK

OTRK is the next short squeeze target. The hedge funds are shorting this one heavily. The stock has dropped from $60 to under $25 in the last few days. A big deal is being made of the company losing their largest client but even with that loss, they still expect revenue to grow next year. Another thing you'll notice is a ton of news releases from ambulance chasing lawyers that are trying to create negative headlines. We think that some of these firms might be in bed with the hedge funds to try to put more negative sentiment on the stock and doubt into buyers' minds. This is a telltale sign of Wall Street trying to push it down to maximize short gains. After several red days in a row, it actually bounced quite nicely mid-day from less than $23, a sign that a bottom has been hit.  

OTRK has a similar short interest as RKT, which has done very well on the back of a short squeeze lately. Look at the stats from Yahoo:













30.68% short interest. There is 7.23 million share float and 2.52 million shares short so that percentage is actually higher at around 35%. Keep in mind though that this data is only up to February 12. The stock has dropped from $85 since then. You'd think that shorts would cover at these prices, but no it's the opposite. Short volume has increased since then according to nakedshortreport.com:

In the days leading up to the 12th, short volume averaged 40%, in line with the short interest data we saw up to that point. Since then, and in the days leading up to the announcement, we see that short volume went as high as 74% and averaged 55%. The hedge funds obviously got word of some news leak. Now you would think that after the stock tanked and the news is out, those short positions would be closed and short volume would go down. But the average short volume over those past four days has been 52%, barely a drop from the days leading up to the news and much higher than the first part of the month. 

The short interest as a percentage of the float could be over 50% right now. This makes a much better squeeze candidate than AMC and might be second only to GME. This stock could easily race back up on a short squeeze. 

Comments

  1. UnknownMarch 5, 2021 at 3:36 AM

    The pot stocks are all getting sborted too

    ReplyDelete
  2. dtailMarch 6, 2021 at 2:51 PM

    Huge potential for this stock. The fundamentals are there. They lost a big client - but the foundation is solid. It's a bargain buy.

    ReplyDelete
  3. skipmannMarch 9, 2021 at 4:51 PM

    You need to add $PPBT to this list...NT219 curing cancer in humans, Morgan Stanley purchased %5 of the company earlier this month, low float, Sabby's vulture fund shorting it to hell - would love to see this go into a gamma squeeze and obliterate the shorts. Who would short a potential cancer cure?

    ReplyDelete

Post a Comment

Popular posts from this blog

Carvana: The Gamma Squeeze is Real, Time to Bankrupt Kerrisdale

Image
Heavily shorted Carvana Co. (CVNA) is in the middle of a squeeze. One that looks eerily similar to the beginnings of the one we saw on GME that eventually made it run to $400 and took down Melvin Capital. Once again certain market players or commentators who focus on fundamentals and who misunderstand or downplay the short squeeze thesis will only add fuel to the fire as they short the stock. Will Carvana be able to refinance its debts next year? Will it become profitable by then? Who knows, and who cares. 2024 isn't the timeline here. The timeline starts as early as June 16, 2023. Triple witching day on options. This time Kerrisdale Capital is the target. The firm is in a desperate spot because the last short call it made was C3.ai, Inc. (AI). AI is in the middle of its own short squeeze and has nearly doubled into $40's since Kerrisdale tried taking it down: The AI report is still featured alongside on the CVNA one on Kerrisdale's website , so we can assume this position
Read more

The Next NVDA-Backed Runner and New Asian IPO Squeeze Play

Image
We have seen stocks like Super Micro Computer, Inc. (SMCI) and SoundHound AI, Inc. (SOUN) have incredible squeeze runs thanks to their connection to NVIDIA Corporation (NVDA). We think the next one will be Spire Global, Inc. (SPIR), which popped a week ago after it announced a collaboration with NVDA to enhance AI-driven weather prediction. A few day later it dropped on the announcement of a financing at $14, with the potential to raise $61 million if warrants at $14.50 are exercised. We think there is a good chance that NVDA got in on this financing, as it tends to invest in the companies it does these deals with when spreading AI across different sectors. One such recent example was with Recursion Pharmaceuticals, Inc. (RXRX) for AI in drug development.  It looks like SPIR didn't really need this financing as it has enough cash and looks like it will be cash flow and net income positive in 2024. This financing was of a strategic nature, not something led by brokers to fund a com
Read more

CVNA Squeezing, ROOT and RXRX are Next

Image
Earlier today we stated that Root, Inc. (ROOT) and Recursion Pharmaceuticals, Inc. (RXRX) were next to squeeze after Carvana (CVNA). One month ago  we mentioned  the gamma squeeze potential on CVNA. Now that this is at hand and the stock has more than doubled, it's time to go long on two other heavily shorted stocks that stand to benefit from the CVNA squeeze as desperate shorts have to cover.  The strategy worked perfectly as ROOT increased 19% and RXRX increased 16% on the day while CVNA rose another 40%. This will be just the beginning as shorts are hemorrhaging on multiple related positions. If you look at the chart for the day, it becomes very clear how highly correlated these three stocks are right now. This is undeniably a sign that shorts, particularly algo HFT shorts are covering simultaneously held positions.  CVNA  made a $126 million investment  into ROOT and has embedded its insurance program into its systems. So any improvement in financial performance on CVNA implie
Read more